ENVALITH
株式会社 鈴木 logo

SUZUKI CO.,LTD.

6785・Prime Market・Electric Appliances

Official website
株式会社 鈴木 logo
SUZUKI CO.,LTD.6785

Business

Suzuki Co., Ltd. is a precision components and equipment manufacturer founded in 1933 and headquartered in Suzaka City, Nagano Prefecture. The company operates through four segments—Molds, Components, Machinery & Equipment, and Leasing—with the Components segment, centered on Connector Contacts and Automotive Electrical Components, accounting for approximately 77% of net sales. In addition to its domestic operations, the company has built a global framework with production and sales bases in China (Zhongshan), Hong Kong, Thailand, and Indonesia. Major customers include Sumitomo Wiring Systems (26.5% of sales), DDK (THAILAND) Ltd. (13.3%), and Terumo (8.4%). The company is listed on the Prime Market of the Tokyo Stock Exchange.

Business Model

The Molds segment serves as the technological foundation, achieving high production efficiency by transferring its precision processing know-how into mass production technology for the Components segment. The Components segment leverages a multi-site production system spanning domestic and overseas locations to supply large volumes for smartphones, automotive, and semiconductor applications, generating the majority of the Group's profit. The Machinery & Equipment segment complements this with high-value-added earnings from made-to-order production of automated devices and Medical Equipment. Capital expenditures are funded primarily through internal resources, expanding production capacity while maintaining financial soundness.

Company Strengths

Since its founding in 1933, the company has accumulated technology in Precision Press Molds and Precision Mold Dies. It holds IATF16949 certification (obtained January 2023), enabling stable supply of high-precision components. Starting from mold technology, the company has expanded horizontally into components mass production, automated equipment, and Medical Equipment, differentiating itself through unique technology fusion.

In addition to multiple domestic plants in Suzaka City, Nagano Prefecture, the company has supply bases for Suzhou Toshin Electronics (Zhongshan), PT. SUGINDO INTERNATIONAL (Indonesia), and DDK (THAILAND) Ltd. Production results for the Components segment in FY2025 (ended June 2025) reached ¥26,714 million, up 27.1% year on year, demonstrating strong global supply capability.

As of the end of FY2025 (ended June 2025), the equity ratio stood at 67.7%, with total net assets of ¥27,901 million. Against interest-bearing debt of ¥2,454 million, the company held cash and cash equivalents of ¥6,157 million, placing it in a state close to substantially debt-free management. Operating cash flow was steadily generated at ¥5,500 million, giving the company sufficient financial strength to fund capital expenditures and dividends from its own resources.

ENVALITH's Perspective

Operating profit of ¥4,444 million for the cumulative nine months of Q3 FY2026 (ending June 2026) has reached 78.4% of the full-year forecast of ¥5,670 million, putting achievement of the forecast well within range with one quarter remaining. The structure in which the Components segment's segment profit, up 27.1% year-on-year to ¥4,621 million, generates the majority of company-wide profit remains unchanged, with the external demand environment (as a market condition) related to smartphones and semiconductors functioning as a tailwind. The company's comment that there is no revision to its earnings forecast is also reassuring.

Investment securities surged approximately 2.4-fold from ¥2,574 million at the end of the previous fiscal year to ¥6,164 million, with valuation difference on available-for-sale securities expanding from ¥1,503 million to ¥3,978 million. While this is the main driver of the increase in net assets, deferred tax liabilities also surged from ¥203 million to ¥1,330 million, meaning that in a reversal phase of stock market conditions (as an external factor), there is a risk that the contraction of the valuation difference and the resolution of the tax liability could occur simultaneously. In assessing the substantive business value, close attention needs to be paid to fluctuations in the market value of the shares held.

The risk of sales concentration on major customers continues as a structural issue. In addition, the trends in U.S. tariff policy, the slowdown of the Chinese economy, and geopolitical risk (as external factors), which the company itself refers to, could pose potential downward pressure on the global production system, which includes sales of ¥6,410 million in China (21.6% of the total) and ¥2,960 million in Thailand (10.0% of the total). While foreign exchange gains of ¥123 million were recorded in Q3 of the current fiscal year, it is also necessary to estimate the impact on earnings should the benefit of the continued yen depreciation dissipate.

Growth Strategy

Pursuing sustainable growth through strategic investment in three domains—automotive components, medical assembly, and automated equipment—alongside development of new business areas

The company is reliably capturing rising demand for smartphone-related and semiconductor-related components within its core Components segment. In the cumulative nine months of FY2026 (ending March 2026) [Q3], the Components segment achieved sales of ¥23,293 million (up 23.0% year on year), and the company continues to strengthen its supply capabilities by leveraging its global multi-site production network.

In the Molds segment, orders for electronic device and automotive electrical component applications trended firmly, achieving cumulative nine-month sales of ¥1,104 million (up 30.0% year on year) and segment profit of ¥252 million (up 45.1% year on year) in FY2026 (ending March 2026) [Q3]. Mid- to long-term demand growth is expected against the backdrop of ongoing EV adoption and electrification in the automotive market environment.

Owing to steady performance in automated equipment and rising demand for medical equipment, the Machinery & Equipment segment achieved cumulative nine-month sales of ¥5,212 million (up 9.8% year on year) and segment profit of ¥659 million (up 20.1% year on year) in FY2026 (ending March 2026) [Q3]. The company's strategy of capturing growth in factory automation and the medical field (as part of the market environment) through its own product lineup has proven successful.

The company has stated that it is working on improvements to maintain stable quality and enhance production efficiency, while also advancing technology development in anticipation of entry into new business domains. Specific details of the new domains are not disclosed in the earnings report, but expanding business through application of existing technologies is positioned as a mid- to long-term strategy.

Last updated: July 17, 2026